The broad goal of this proposal is to understand the oncogenicity of transcriptional regulators. The work will focus on Jun and proteins that interact with Jun. The general working hypothesis is that Jun induces oncogenic transformation by virtue of its ability to control the transcription of specific genes. An alternative hypotheses is that the stimulation of DNA synthesis induced by Jun is the critical function for oncogenesis. These hypothesis will be tested by seeking a correlation between oncogenicity and transactivation or stimulation of DNA synthesis using Jun constructs of differing oncogenic potential. A mutational analysis of structural and functional changes affecting oncogenicity of Jun will be carried out to define domains and molecular activities important in transformation. In order to learn more about the regulatory functions of Jun, proteins that interact with Jun will be identified by genetic complementation, anti-idiotype antibodies and screening of expression libraries with labeled fragments of Jun. The regulation of Jun itself will be studied at the transcriptional, translational and posttranslational levels: one of the major aims in this direction is to understand the cell cycle dependence of the nuclear translocation of Jun. Target genes that are controlled by Jun and play an important role in oncogenesis will be identified with regulatable Jun constructs. Cooperation of Jun with additional oncogenic events will be studied in the transgenic mouse model. The interference of Jun with the MyoD induced transcriptional program will be analyzed at the molecular level. Recently isolated highly oncogenic retroviruses will be examined for novel oncogenes.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Unknown (R35)
Project #
5R35CA042564-13
Application #
2712604
Study Section
Special Emphasis Panel (SRC (88))
Program Officer
Cole, John S
Project Start
1986-06-01
Project End
2000-05-31
Budget Start
1998-06-01
Budget End
1999-05-31
Support Year
13
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Harada, Josephine N; Bower, Kristen E; Orth, Anthony P et al. (2005) Identification of novel mammalian growth regulatory factors by genome-scale quantitative image analysis. Genome Res 15:1136-44
Nishizawa, Makoto; Fu, Shu-Ling; Kataoka, Kohsuke et al. (2003) Artificial oncoproteins: modified versions of the yeast bZip protein GCN4 induce cellular transformation. Oncogene 22:7931-41
Nishizawa, Makoto; Kataoka, Kohsuke; Vogt, Peter K (2003) MafA has strong cell transforming ability but is a weak transactivator. Oncogene 22:7882-90
Jiang, B H; Jiang, G; Zheng, J Z et al. (2001) Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ 12:363-9
Aoki, M; Blazek, E; Vogt, P K (2001) A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt. Proc Natl Acad Sci U S A 98:136-41
Maslyar, D J; Aoki, M; Vogt, P K (2001) The growth-promoting activity of the Bad protein in chicken embryo fibroblasts requires binding to protein 14-3-3. Oncogene 20:5087-92
Mende, I; Malstrom, S; Tsichlis, P N et al. (2001) Oncogenic transformation induced by membrane-targeted Akt2 and Akt3. Oncogene 20:4419-23
Cohen, S B; Waha, A; Gelman, I H et al. (2001) Expression of a down-regulated target, SSeCKS, reverses v-Jun-induced transformation of 10T1/2 murine fibroblasts. Oncogene 20:141-6
Jiang, B H; Zheng, J Z; Aoki, M et al. (2000) Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci U S A 97:1749-53
Xia, Y; Zhang, Z; Kruse, U et al. (2000) The new serine-threonine kinase, Qik, is a target of the Qin oncogene. Biochem Biophys Res Commun 276:564-70

Showing the most recent 10 out of 76 publications